Axa’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,200
Closed -$286K 1132
2022
Q3
$286K Buy
+18,200
New +$286K ﹤0.01% 1047
2019
Q3
Sell
-263,888
Closed -$578K 1292
2019
Q2
$578K Sell
263,888
-334,272
-56% -$732K ﹤0.01% 1069
2019
Q1
$3.58M Buy
598,160
+216,212
+57% +$1.3M 0.01% 730
2018
Q4
$2.82M Hold
381,948
0.01% 751
2018
Q3
$5.55M Hold
381,948
0.02% 642
2018
Q2
$7.63M Buy
381,948
+87,250
+30% +$1.74M 0.03% 532
2018
Q1
$5.16M Buy
294,698
+32,939
+13% +$577K 0.02% 642
2017
Q4
$6.46M Buy
+261,759
New +$6.46M 0.03% 595